It found that there the group treated with imipenem had a significantly lower rate of complications 33% versus 59% p < 0.05 and less pancreatic and extra pancreatic infections 14% versus 43% than did the group receiving placebos.
59% p < 0,05 y menos infecciones pancreáticas y extrapancreáticas 14% vs.